IL-15 activated human peripheral blood dendritic cell kill allogeneic and xenogeneic endothelial cells via apoptosis

Cytokine

Volumn 61, Issue 1, 2013, Pages 118-126

  Manna, Partha Pratim ^a   Hira, Sumit Kumar ^a   Das, Apabrita Ayan ^a   Bandyopadhyay, Santu ^b   Gupta, Kailash Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Apoptosis; Dendritic cell; Endothelial cell; IL 15

Indexed keywords

CASPASE; CD14 ANTIGEN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; GRAFT REJECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD14; AORTA; APOPTOSIS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; ENDOTHELIAL CELLS; GRANZYMES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MONOCYTES; SWINE; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

SUS;

EID: 84869880818     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.004     Document Type: Article

References (40)

1. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
2. Agostini C., Trentin L., Facco M., Sancetta R., Cerutti A., Tassinari C., et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996, 157:910-918.
3. Burton J.D., Bamford R.N., Peters C., Grant A.J., Kurys G., Goldman C.K., et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994, 91:4935-4939.
4. Di C.E., Comes A., Basso S., De A.A., Meazza R., Musiani P., et al. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J Immunol 2000, 165:3111-3118.
5. Kirman I., Nielsen O.H. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 1996, 91:1789-1794.
6. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996, 2:175-182.
7. Baan C.C., Niesters H.G., Metselaar H.J., Mol W.M., Loonen E.H., Zondervan P.E., et al. Increased intragraft IL-15 mRNA expression after liver transplantation. Clin Transplant 1998, 12:212-218.
8. Pavlakis M., Strehlau J., Lipman M., Shapiro M., Maslinski W., Strom T.B. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996, 62:543-555.
9. Smith X.G., Bolton E.M., Ruchatz H., Wei X., Liew F.Y., Bradley J.A. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol 2000, 165:3444-3450.
10. Ferrari-Lacraz S., Zheng X.X., Kim Y.S., Li Y., Maslinski W., Li X.C., et al. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001, 167:3478-3485.
11. Li X.C., Schachter A.D., Zand M.S., Li Y., Zheng X.X., Harmon W.E., et al. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. Transplantation 1998, 66:265-268.
12. Li X.C., Roy-Chaudhury P., Hancock W.W., Manfro R., Zand M.S., Li Y., et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol 1998, 161:890-896.
13. Baan C.C., Knoop C.J., van G.T., Holweg C.T., Niesters H.G., Smeets T.J., et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 1999, 67:870-876.
14. Kumaki S., Minegishi M., Fujie H., Sasahara Y., Ohashi Y., Tsuchiya S., et al. Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. Int J Hematol 1998, 67:307-312.
15. Martin K.R., Wu D., Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis 2000, 150:265-274.
16. Ryan U.S., Clements E., Habliston D., Ryan J.W. Isolation and culture of pulmonary artery endothelial cells. Tissue Cell 1978, 10:535-554.
17. Manna P.P., Mohanakumar T. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro. J Leukocyte Biol 2002, 72:312-320.
18. Manna P.P., Duffy B., Olack B., Lowell J., Mohanakumar T. Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naive T cells through costimulation and cytokine generation. Transplantation 2001, 72:1563-1571.
19. Li X.C., Ima A., Li Y., Zheng X.X., Malek T.R., Strom T.B. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. J Immunol 2000, 164:1193-1199.
20. Kinoshita N., Hiroi T., Ohta N., Fukuyama S., Park E.J., Kiyono H. Autocrine IL-15 mediates intestinal epithelial cell death via the activation of neighboring intraepithelial NK cells. J Immunol 2002, 169:6187-6192.
21. Lechler R., Ng W.F., Steinman R.M. Dendritic cells in transplantation-friend or foe?. Immunity 2001, 14:357-368.
22. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000, 191:423-434.
23. Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996, 183:1789-1796.
24. Josien R., Heslan M., Soulillou J.P., Cuturi M.C. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. J Exp Med 1997, 186:467-472.
25. Fanger N.A., Maliszewski C.R., Schooley K., Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999, 190:1155-1164.
26. Ruckert R., Asadullah K., Seifert M., Budagian V.M., Arnold R., Trombotto C., et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?. J Immunol 2000, 165:2240-2250.
27. Brandt K., Bulfone-Paus S., Jenckel A., Foster D.C., Paus R., Ruckert R. Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol 2003, 121:1379-1382.
28. Brandt K., Bulfone-Paus S., Foster D.C., Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 2003, 102:4090-4098.
29. Ruckert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R., Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 2003, 33:3493-3503.
30. Niedbala W., Wei X., Liew F.Y. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro. Eur J Immunol 2002, 32:341-347.
31. Ruckert R., Brandt K., Braun A., Hoymann H.G., Herz U., Budagian V., et al. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol 2005, 174:5507-5515.
32. Liu K., Catalfamo M., Li Y., Henkart P.A., Weng N.P. IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci USA 2002, 99:6192-6197.
33. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999, 17:19-49.
34. Mastroianni C.M., d'Ettorre G., Forcina G., Lichtner M., Mengoni F., D'Agostino C., et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 2000, 96:1979-1984.
35. Naora H., Gougeon M.L. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15. Immunol Lett 1999, 68:359-367.
36. Mueller Y.M., Bojczuk P.M., Halstead E.S., Kim A.H., Witek J., Altman J.D., et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 2003, 101:1024-1029.
37. Lum J.J., Schnepple D.J., Nie Z., Sanchez-Dardon J., Mbisa G.L., Mihowich J., et al. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 2004, 78:6033-6042.
38. Bratke K., Nielsen J., Manig F., Klein C., Kuepper M., Geyer S., et al. Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation. Clin Exp Allergy 2010, 40:1015-1024.
39. Vosshenrich C.A., Lesjean-Pottier S., Hasan M., Richard-Le G.O., Corcuff E., Mandelboim O., et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007, 204:2569-2578.
40. Chaudhry U.I., Plitas G., Burt B.M., Kingham T.P., Raab J.R., DeMatteo R.P. NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo. J Immunol 2007, 179:4654-4660.